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lha nood tor cllnical lrlnls wllh ontioxldflnla according lo Iho Hp pnonatypo 01 
Iha pallonls. 
1064-r) Reduced Response to Activated Proteln C and 
InherIted Factor V Mls-aenee Mutatlon In Patients 
With a History of Acute Myocardlal ntarctlon or 
Eeesntlal Hypertenalon 
Th.K, Makrla, F?Q. Kmapl, A.N. Halxlxnchflrlsa, AI% Glalerakl, 
G.P. Anaatnatnd\s. N.V. Dnttnnta, V.E. Vottans, C.D. Panag\otopoulou. 
T.E. Mandalakl, M.K. Kyrlflkldls. Cnti/~?/ag,v OPpf. - 2nd I%?@ R~-~anmo% 
Lab, LAIKO OFn. mp. PI Alhens, @Qa6% 
Bn&kgr~~mff: lwl~tnnon 1~ RG~RI~~ prolain 6 (APCI which rnaulla Imm 
varloua tactara, lncludtng n mutallon In lha gana for fiaagulanl lnclor V (FV), 
hns bean dnmanslrnlad na A rtak tnclor tar vanoun lhmmbaale. Maraovar, 
lnhntltod lacfar V mln.aanna point mutnllon, FV Q!XIO haa racontly baan 
tdantltlad aa a mn\or QGUR~ ot fnmlllnl vanoua thromboslrr: but thorn la tlttla 
lnlonnnllon about lhalr aaaacmllan wllh artsrlnl thramhosls Thea nludy wns 
doslgnod lo Invaallgala both. raapanaa lo APC nnd Iha factor V mulnllan 
Irlcldanco In Qrenk pnllanlw (plo) wllh a hlslary al naula myoonrdlnl tnlamllon 
(astabllahad oriarlnl lhrombaala) nnd pta with aRAart\II\\ hypartondon. a lqh 
rlak group tar nnarlnl Ihmmboals. 
M@lhc&?: 4R pla with a hlnlary al myo%?rdtnl inlmclton (Rrairp A), 80 
pI8 wlh a hlalory ot QRsOnltal hyparlunalan (Graup 8) and 62 flga-matchad 
control8 wllhaul nrtorlnl dlaanao (Group C) warn shldmd, Pnlionte usmg 
anllcongulnnl drugs WOM ox&dad. Rnspanno la APC wnfl dotorminod in 
daubla conlrttugod plnlalal poor plnsma. Pnllonla waro gonatypo tar Iho Arg 
506 to Qln mutallon m lha nana for cangulnnt fnotor V, 
F!&+%JII?J: The lncldenca al lhn mulollon wna XI%, 13.75% and 6% in lho 
@nupa A, R nnd C mspocllvaly. l’ho lncldonco al rmiucod mnpanao lo APC 
was 47.5% In group A vs 13% In ~mup C (p . O,gOr) nnd 36.25% In group R 
VR 13% In amup C (O.OQl . p .. O.Ot). Tho ruaponsn to nctlvated pmtain C 
(APC) expmanad ns mann vnkio i SD was 2.05 -I, 0.36 In group A vs 2.56 t 
0.49 in group C (p . 0.001) nnd 2 .I 0.18 In gmup B VR 2.58 I 0.40 In group 
c (p i aoar). 
Conckislon: Qur hndngs sugqast thnt Gmok pntlonts with R history al 
acute myo-znrdlnl lnlnml~on or ossonllnl hyporlonalon hnva n slgmlicanlly 
lncmnsod lncldonco ol both mducod msponso lo APC and lnhonlod laclor V 
mUnllon In compnnson lo Iho canlrol graup. Thoso prellmlnnry rusults rniso 
lho posalblllty Ihnl mducod msponso la APC mny bo n rlak tactor tar artonr~~ 
dlsonsa. 
1___3 1064-5 Plasma Apollpoproteln B Levels Predict Platelet-dependent Thrombosis In Patlents Wlth 
Coronary Artery Ulsease 
M Shochlor. C N 0 Morz. M Paul-Labrador, M.D. Mo\loy, 0 Corcoh. 
P.K. Shnh. S Knul. Cedars-Stnnr Medical Center. CA. USA 
Elovatod plasmn npokpoproloin (ape).R leval is n known nsk Ior atheroscta- 
rotlc CAD, howavor Its mlatlonshlp to anorial thromhosm ts unknown. We 
prospoctlvoly nssessod npo-Et and platelet-dapondonl thrombosis (PDT) in 
42 stablo CAD pattents on flsplnn and Ilpld.loworing therapy. by exposing 
porcine aorl~c media lo tholr llowtng nonanllcunguleted venous blood for 5 
mhutos at a shonr rata ot 600 sot ’ a1 37% using an ex-vivo flow cham- 
hor model Tho PDT was measured by computerized morphomotry and 
oxprossod as ,rrn:/mm of tho aomc surface 
&?slrlls: PDT was s~gnillcantly correlated wilh apo.R (Figure). PDT did 
nol cOrreQIo wrlh sorum Idal cholesterol (171 .I 26 mgldL. r = 0.3). CDL-C 
(102 t 26 mg/dL. r = 0.2). HDL-C (41 t 10 mg/dL. I = 0.1). apo A-l (126 
t 16 mg/dL, r = 0.1) or fibnnogen levels (296 f 60 mgidL. r = 0.1) (values 
are maan t SO: all p = NS) 
Concfus~on: Elevated apo-Et levels are associated with augmen~sd PDT 
in stable CAD patients despite controlled lipid levels. These findings suggest 
!hat the positive relarionship of eleva&d apo8 lo CAD may be, in part. related 
lo IIS prolhrombotlc effects 
Varlqhlllty end Aesoclatiir,le of Flbrlnogen and 
gird31ve Proteln In the Framingham Offspring 
I, Llplnska, D. Feng? P.W.F. Wilson, MA. Mlltloman, J E. Muller, 
P. Sufhorlnnd, t-t. Sllberahotr. A 8. D Agosllno. D. Levy. G.H, Tollor, Boll, 
$meI Daaconess Med/cal Cantor, Fmmhgham Heart Study, Boaron, MA, 
USA 
Fibrlnogan and C-roackva prutaln (CRP), 2 Inflammatory mnrksn that pmdtct 
cardtovaecular dtrroasa, may bs uaalul In assenaln~ shangt3s in risk. To 
determlns varlabltlty and asaoclattons avar ilma, we measured fibrinogen 
(Clausa method) and CRP (ELlSA) In 100 sub]acls (50 men. 60 women) 
tram Iha FramIngham OHsprtng Study OvQr I +yaar Interval (ago at btialtns 
wns 64 c 10 yanra). Tham wna n clean carmlatien between ba8altne and 
lallaw=up I~als (1~ figure), Enaallna LbrtnaQen G!l2 -t 8s mgfdl) incresaed 
by 6% (p 3 0,087) nnct CRP (X82 % 331 m@l) by 6% (R J NS). Them was 
nlaa a eigntftsnnt correlation batwaon bbnnogon and CRP both at baserma 
(R 9 0.6% p ‘: O.pOl) and tollow.up (R 6” 0.87, p i %aOl), supporllng a bnh 
bdwonn mflsmmnl~on and n pmlhrombr3i6 R~RIO. 
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Doapilo Doing acute phase ranclanls. bolh libnnogen and CRP were rel- 
ntivaly stablo over lho 4.yoar pmtod. suggesling Ihat longiludinal ctlttorcms 
may provide inslght mlo changing cnrdtovascular risk. 
1064-7 Hlgh lncldence of Chlamydla Pneumonlae In 
Atherosclerosis of Coronary Arteries With Both 
Genus and Species Spaclfic Antlsera 
E.H Hammond. J.B. Muhleslem, T.H. Hammond, J.F. Carlqulst, 
J.L. Anderson 1D.S IfoSpital. Umversrty of Utah, Salt Lake Cl@, Utah. USA 
6ackgmund: We have previously rcponcd the prevalence of chlamydlal anti- 
gen m coronary atheromas lrom symplomallc pts undergolng dm?ctlonal 
alherectomy and m control pts. In thal sludy. we used a genus.specillc an- 
tlbody (G-ab) recognizmg a chlamydral lipopolysamhande on trozen Ussue 
samples by ~mmunocytochem~stry 
A$e?bo&: We sought to extend and compare our observattons by retestmg 
those alheroma and control samples for the presence of a specros~specdic (C 
pneumomae. RR 402) antIbody (S-ab). We used frozen lissue samples and 
a slandard immunocytochemical approach (indirect immunolluorescence). 
Results: We found 911114 (79.6%) athereclomy samples from CAD pa 
tlonts were posItwe wllh G-ab and 25/47 (63.2%) were positive ~vllh S-ab 
Kappa slnlislic lor the relation between the staining resul1 seen wvilh lhese 
antibodies was 0.047. showing only marginal agreement. Conlml tissue from 
cornnary artenes of pallents dying of traumatic causes wilhoul alhemsclero- 
SIS was porllive m 0121 wllh G-ab and 2/21 (9.5ob) wllh S-ab. Patlents with 
Imnsplant-rc’sttct coronary disease had O/12 samples positwe wllh G-ab and 
l/12 (6%) with S-ab. However. the dltterences between immunoposilivily m 
atheroma versus control samples were significant for both G-ab (p = 0.001) 
and S-ab (p = 0.01) Two of three batches of S-ab caused unacceptably high 
levels of background statmng. 
Conclusions: Chlamydlal antigen prevalences detected by either G.ab 
or S-ab immunocytochemistry are Increased in coronary alheroma samples 
compared to controls. SensitivQ and reliability at G-ab IS higher, kkety due 
lo the lower avtdity 01 S-ab lo chlamydial anllgens and higher background 
starwg. The posstbibty of > 1 chlamydral specfes betng involved in athero- 
sclerosis cannot be excluded. 
k-q The Prevalence of Chlamydia Pneumonlae In 
Atherosclerotic and Normal Blood Vessels of 
Patlents Undergoing Redo and First Time Coronary 
Artery Bypass Graft Surgery 
Y. Wong. M. Thomas, P.J. Gallagher, V.T. Tsang. M.E. Ward. Southampton 
General fiospital. England 
Background: Studies have suggested inlriguingly that Chlamydia Pneumo- 
n&O (c. pncumor~?e) causes coronary artery d~seasu. There are saverat 
reports that Ihe argantrm IR found m diseased but no1 normal coronary ar. 
lanes. For the hrs;l time. wo have studied whole segments of diseased and 
norm%1 blood vesnets (mm IN0 paltents 
Method’ From 38 paltonls undergoing redo and 9 patients undergoing 
lust bmo cotonety artery byp%es graft aurgmy. tntmls ot occluded venous 
graft% Of %lh%f@&tny Ot tl%tiv% rZoRXl%rY veS%el% were obtained along with 
eegments ot nonni?l saphenous vem and int%m%l tnammmy arteery (IMA) G. 
pneumon& DNA w%% ctwcked tot by tC @ytnof%8% chain m%ctkm (PCR) 
conctusKrm c mae is unfikety to ke a direr3 cause of athefoacfe- 
fosrs as tt 1s kxmcl Ihra@o@ the ~scdar k?e fncfcadmg fhe IMA whrch IS not 
assoccated wtth a!heroecterosis. Nowever. we have not ruled oul an tndx%ct 
el?ect such as increasmg the cwagulalnlty of b!ood ur mat It ex,acecbates 
Pm-eXlstmq ptaques 
lzzl 1064 9 Risk Factors in +TMm Populations at ContrastIng 
Risk for Coronary Amy Diise 
J. Fetires. A. Evans. P. Anxxiyel. D. Awetler, J. Yamell. J 8. Awdaveb. 
I-J. Vague. J.C. Fruchart. G. Luc. PY. Scarabm. F Cambten, P Ducrmetlere. 
Cam De@Tmenl CtfU Purpan. fb&use. France 
Backgruuncf. The mctdence ot coronary artery disease (CAD) m m&lbagea 
men IS more than three bees higner m Not-Wrn Ireland than m France. The 
PRIME Stu@y, based on WHO MONICA Centers in Belfast (Northern treland, 
2748 men), U!te (Nonhem France. 2627 men). Strasbourg (Eastem France. 
2611 men) andToutousa(Sauthwestem France, 261Omen). rsacohortstudy 
m which we pian to analyze the m+tirtco of CAD nsk factors m men aged 
4S-KI years over a penod ot 5 years 
Meethcds: We compared the nsk factor level between 451 CAD subfects 
(prewous myocardial mtarchon or angma) al entry and 10145 &as&me 
subtects Ctkxcal variable-s (age. body mass index. b&d pressure. cigarette 
smokmg. diabetes melktus. alconol consumptron). fibrinogen levels and an 
u+&plh SALK& 01 l~pcl vanables [total cholesterol. tnglycende. HDL choles- 
terol, apokpopmtem (ape) At, apo 8, kpoprotem parttcle (Lp) Al. Lpa (a) Lp 
BE) were analyzed m this p:t?valence case-conrrol study 
ResurSr After aqustement for age. body mass index. blood pressure level. 
crgarette smokmg. dtab-etes and alcohol consumption. m Norlhem Ireland and 
France, patients m comparison wtth controls (p _ 0.01) had lower levels of 
HDL cholesterol. apo Al. Lp At and hrgher levels 01 fibrinogen. mgfY.Xride. 
apo 8. Lp BE and Lp (a). In two countnes wrth stnkmg dtfferences In CAD 
nsk. differences between cases and contmls were srmllar. However. Lp (a). 
Lp 6:E and fibrinogen levels were htgher and Lp Al levels were tower m 
Northern lnsh than tn French contmls (p q 0.001). 
Cotiusron: These results could explam part of the larp excess of CAD 
observed m Northern Ireland and the prospectwe pan of Ihe study will permet 
to quanttfy 11. 
\1064-10 ] Enhanced Expression of Endothelin-Converting 
Enzyme Is Associated With the Pmgression of 
Coronary Aiherosclemsis in Humans 
Takahiko Naruko. Makiko Ueda. Kazuo Haze. Allard C. van der Wal. Chris 
M. van der Loos. Kazuhlko Tanzawa. Antol, E. Becker. O&a Cify Genera/ 
Hospffal. Osaka. Japan; Academic Med;ca/ Center. Amsterdam. The 
NerheCnds 
Background: Endolhelin-1 is a potent vasoconslrictor and presents a mlto- 
genie ac’ vity on vascular smoath muscle cells (SMC). Endothelmconvertmg 
e.?:yme (ECE) is the final key enzyme al endathelin-1 processing. We stud- 
ied the expression of ECE in human coronary athemsclemlrc lestons. using 
immunoc@chemical techniques. 
Methods: Fmzen sections. normal with diffuse intimal thickening (DIT; n 
= 23). and diseased, with early alherosclemtlc plaques (early AP: n = 6). 
and advanced atherosclerotic plaques (advanced AP: n = 18) were studied. 
Monoclonal antibodies were directed against SMC. macrophages (Ma). en- 
dothelial cells (EC), and ECE (AEC32-236). For the identification of cell types 
which express ECE, the immunodouble staining method was alS0 used. 
Moteculsr and Gfmatic Studka of uptd 
DI~ORIWQI 
MCVtelay, March 30. 1998,3:00 p.m,d:OO pm, 
(4eof9ia World Gonqress Gentar. Wea Exhibit Hall Lswl 
Preslentalian Hour: 3:OO p.m.--400 p.m. 
We haM rdenbfii 4 famtty rn New York Slate wttt mulatrons in both the 
llpoprofeln kpase (LPLJ gene and %pol@opmtam (ape) A-l gene. A -Q3TiG 
-tin n the LPL pornofor regcon was &nt&xl in 0 tamtly members. 
In addition. 2 ptewously umapocted mutations m ttw LPL promotor rem. 
~634Mand -755 G/Asegregeted withthe -93 TKi transitron mefl%tiected 
sub(ects. A bas+p%ir substiiutmn m Me apoA-I gene (Phe” - Tyr) was al%0 
rdenttfti m 12 biologtc tamiiy members. Mean levets ot Itp@s. iiins 
and apolipopmtetm m subpxts w#h the LPL vanants or ApoA-I Ptattsburgh 
(Phe” -TV) compared to unafiected family members (controls, n = 16) are 
shown m the Tabte Compared IO controls. sub@cts Wm, the LPL vanants had 
stgnrfcantty lower HDL-C (p = 0.03) and apoA-I (p = 0.03). Apia_I Platt%&urgh 
was -ated mth s&!ndrc%ntly tower HDLC (p = 0.02). The proband wnh 
%poA-I Plattsburgh (TC = 192 m$lL HDLG = 6 mg/dL. apuA-I = 24 nTg@LJ 
developed CAD at age 44 ym. Premature CAD also occumzd m assock?tion 
wlm the LPL promotor vanant. These data demonstrate that HDL-C may be 
mlluertced by more th%n one major gene candrdare wrthrn the same famdy 
and that vanants m the LPL promotor regton contribute lo low HDLG 
Mutanan TC HOL LOL TG A&MA-I AWB 
LPL 931.” 203 34 143 155 86 z- 
np0A.l 174 3i) 103 121 116 106 
COnfrOlS 199 47 128 186 127 e9 
]1065-12 Llpopmtein Lipese Gene Polymorphisms Are 
Predictors of Risk of Coronary Artery Disease 
and Myocardbl Infarclion 
J.l_ Anderson. G.J. Kmg. S.P. Elmer. T.L Barr. J.B Muhlestein. 
J.F. Carlquiet. LDS Hosprfal. Unrvem~ly of Utah S%/I Lake C@! Utah uSA 
&&ground Lrpoprotein llpase (LPLJ plays a cenlral rola m lipfd metabolism. 
hydmtyzmg tnglycende in chylomrcrons anu VLDL. Common polymorphc 
vanants of the LPL gene have recently been rdentltkzd. Those defmed by 
the Hrcdili and pvull restnctron sttes may alter plasma ltptds. We @sW 
whether the* LPL potymorpttphimrs - wtrcaw. the ten common%llde(-J 
or the homozygous genotype (--I-) - mtght be PrediCtOfS Ot InCTeaSd n9k 
tw -2ry artery tttsease (CAD) and mywrdral &KZF~K~? (f&J. 
Metnods: Blood was drawn tmm 1067 Conseclnhre corIsemlng Pt un. 
dergotng coronary angmgraphv Segments contammg Ihc site ln lntmn 8 (“1 
I 067) and the site m mhon 6 (nt 685) were ampllticd by the potV6nsc Cha’n 
reactton and dIgested. Polymorphrsms Were ldentltied aner el~~~s’s 
m t .5?!, agamse gel and staining with ethidium bmm@e. 
&su!B: Frequencres ot the (-) allele were 41.9’&. 43.690 for ml end 
27.30~. 27.496 for ~;ndJll in non-GAD (C 10% stenosrs) and non-MI ContrOts. 
respectively. Genotype distributions conformed to Hardy-Wernkrg ema. 
lions; connob homomte (-I-) genotype frequencies were 18.3X 179”. 
jn the 2 ccntrofll groups. re+ily. For Pwull. the homozygote (-‘-J tm- 
quency was not imaged for MI (23.490. OR = 1.4. P = 0.1) Or CAD Pt 
(,609$ StenOsrs) (21 .po. OR = 1.17). overall or m men. However. the (-‘- 1 
oenome was increased (30~ LS is”&. OR -7 2.8. p . 0.008) In women wth 
